Key facts
- This page summarizes Andrew D. Feldman's Form 4 filing for Cerebras Systems Inc. (CBRS).
- 21 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 25 Aug 2026, 18:13.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Gift
Conversion of derivative security
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Sale
Other
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Conversion of derivative security
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The reporting person transferred 50,000 shares of the Issuer's common stock to a donor-advised fund sponsored by a charitable organization under Section 501(c)(3) of the Internal Revenue Code.
Footnote F2
The Class B Common Stock is convertible into an equal number of Class A Common Stock at any time, at the Reporting Person's election, and has no expiration date.
Footnote F3
The sale reported on this Form 4 represents shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026.
Footnote F4
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $195.75 to $196.74, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F5
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $196.75 to $197.74, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F6
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $197.75 to $198.74, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F7
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $198.75 to $199.74, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F8
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $199.75 to $200.74, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F9
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $200.75 to $201.72, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F10
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $201.86 to $202.83, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F11
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $202.90 to $203.87, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F12
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $203.92 to $204.87, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F13
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $204.96 to $205.67, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F14
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $206.81to $207.59, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F15
The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $208.42 to $209.00, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Footnote F16
Represents a pro-rata, in-kind distribution not for additional consideration.
Footnote F17
The stock option vests in 48 substantially equal monthly installments beginning on February 1, 2023.
Footnote F18
The stock option is fully vested and exercisable.